These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 47003)

  • 21. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ligation of hepatic artery combined with radiotherapy in the treatment of unresectable primary liver carcinoma].
    Li GH
    Zhonghua Zhong Liu Za Zhi; 1985 Sep; 7(5):370-2. PubMed ID: 3004857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatoma in cirrhosis. Serum alpha-feto-protein levels after hepatic dearterialization].
    Huguier M; Hirsch-Marie H
    Nouv Presse Med; 1972 Dec; 1(43):2905-6. PubMed ID: 4346284
    [No Abstract]   [Full Text] [Related]  

  • 24. The surgical management of primary hepatocellular carcinoma in Uganda.
    Harrison NW; Dhru D; Primack A; Bhana D; Kyalwazi SK
    Br J Surg; 1973 Jul; 60(7):565-9. PubMed ID: 4352089
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trial of doxifluridine in the treatment of primary hepatocellular carcinoma.
    Lai KH; Tsai YT; Lee SD; Yeh YS; Wang SS; Ng WW; Wang JY; Chiang TT; Lay CS; Yang CF
    Cancer Treat Rep; 1986 Nov; 70(11):1339-40. PubMed ID: 3021327
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemotherapy of hepatocellular carcinoma].
    Okada S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2028-31. PubMed ID: 8586926
    [No Abstract]   [Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
    Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
    Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
    [No Abstract]   [Full Text] [Related]  

  • 28. [Physiologic hepatic dearterialization and 5-FU intra-arterial perfusion in primary hepatic carcinoma].
    Wang CE; Cao XH; Zhen YY
    Zhonghua Wai Ke Za Zhi; 1985 Sep; 23(9):525-7, 571-2. PubMed ID: 3004843
    [No Abstract]   [Full Text] [Related]  

  • 29. Ischemic treatment of liver tumours.
    Bengmark S; Tranberg KG
    G Chir; 1988 Oct; 9(10):651-61. PubMed ID: 2484645
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trial of gestronol hexanoate (SH582) in benign prostatic hypertrophy.
    Gengell JC; Miller IM; Roberts JB
    Proc R Soc Med; 1972 Feb; 65(2):130. PubMed ID: 4117437
    [No Abstract]   [Full Text] [Related]  

  • 31. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of successful combination therapy with trans-arterial embolization, trans-arterial chemotherapy and radiofrequency ablation therapy].
    Ota H; Yasumoto T; Okada K; Ide Y; Maruyama K; Yokouchi H; Mikami K; Kinuta M; Murata K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2103-5. PubMed ID: 19106537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collateral arterial blood supply of the liver after hepatic artery ligation, angiographic study of twenty patients.
    Plengvanit U; Chearanai O; Sindhvananda K; Dambrongsak D; Tuchinda S; Viranuvatti V
    Ann Surg; 1972 Jan; 175(1):105-10. PubMed ID: 4334266
    [No Abstract]   [Full Text] [Related]  

  • 34. [Percutaneous tumor ablation therapy for the advanced stage of HCC].
    Teratani T; Shiina S; Obi S; Hamamura K; Koike Y; Akamatsu M; Fujishima T; Tateishi R; Imai Y; Shiratori Y; Omata M
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1496-500. PubMed ID: 11015992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difficulties in conducting controlled trials in radical therapies for nonadvanced hepatocellular carcinoma.
    Hoshida Y; Shiratori Y; Omata M
    Hepatology; 2000 Oct; 32(4 Pt 1):877-80. PubMed ID: 11041691
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase 2 study of high dose etoposide (VP16-213) in hepatocellular carcinoma.
    Shiu W; Mok SD; Leung N; Li M; Zacharia A; Li A; Martin C
    Jpn J Clin Oncol; 1987 Jun; 17(2):113-5. PubMed ID: 3039199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adriamycin therapy in American patients with hepatocellular carcinoma.
    Ihde DC; Kane RC; Cohen MH; McIntire KR; Minna JD
    Cancer Treat Rep; 1977 Oct; 61(7):1385-7. PubMed ID: 201380
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of irresectable hepatocellular carcinoma with repeated transient dearterialization].
    Huang J; Wang W; Liang L
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):522-5. PubMed ID: 9594153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The hepatocellular carcinoma: alternative therapeutical strategies].
    Spangenberg HC; Thimme R; Mohr L; Blum HE
    Zentralbl Chir; 2007 Aug; 132(4):322-7. PubMed ID: 17724635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma.
    Woo HY; Bae SH; Park JY; Han KH; Chun HJ; Choi BG; Im HU; Choi JY; Yoon SK; Cheong JY; Cho SW; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):373-82. PubMed ID: 19763572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.